Hanmi Pharmaceuticals

Hanmi Pharmaceuticals was founded in Korea in 1973 and has since grown to become one of the top five pharmaceutical companies by revenue, as well as the company with the most concentrated R&D investment over the years. For decades, Hanmi has achieved success through a high degree of flexibility, continuously shifting its market/development strategy from initial generics to IMDs and FDCs (Incrementally Modified Drugs and Fixed-Dose Combinations), and toward the development of new drugs, including innovative small molecules and biologics. During periods of significant change, Hanmi established multiple strategic partnerships with multinational corporations and biotechnology firms.